Ketoderm Eg

Ketoconazole, the active ingredient in Ketoderm Eg, is an azole antifungal presented as a topical formulation for skin application. It treats superficial fungal infections such as tinea corporis, tinea cruris, tinea pedis, seborrheic dermatitis and pityriasis versicolor in both adults and children, and is marketed throughout the European Union.

GNH USA supplies Ketoderm Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and ensures timely delivery to authorized buyers.

Ketoconazole is an azole antifungal that interferes with the ergosterol pathway of dermatophytes and yeasts.

- Tinea corporis: reduces lesion size and clears infection. - Tinea cruris: alleviates itching and eliminates fungal growth. - Tinea pedis: resolves foot scaling and erythema. - Seborrheic dermatitis: diminishes redness and flaking of scalp or skin. - Pityriasis versicolor: restores normal skin pigmentation by eradicating Malassezia species.

Topical ketoconazole may cause local skin reactions and, rarely, systemic effects.

Common Side Effects: - Burning sensation: mild transient heat at application site. - Itching: localized pruritus. - Redness: erythema of treated area. - Dryness: skin flaking or scaling.

Serious or Rare Side Effects: - Contact dermatitis: severe allergic reaction with swelling and blistering. - Hepatotoxicity: rare systemic absorption leading to liver enzyme elevation (monitor if large area applied).

When using Ketoderm Eg, several precautions should be observed to minimize adverse reactions and ensure efficacy.

- Application area: limit use to affected skin and avoid mucous membranes. - Duration: follow prescriber’s recommended treatment length; prolonged use may increase irritation. - Concomitant skin products: do not apply other topical agents on the same area unless advised. - Sensitivity testing: perform a patch test on a small area before full application. - Pregnancy and lactation: use only if benefits outweigh potential risks, after medical consultation. - Store at room temperature: keep below 25°C in the original packaging, protected from moisture and direct sunlight.

Ketoconazole can interact with other topical or systemic agents, altering efficacy or safety.

Major Interactions (Avoid): - Systemic azoles: concurrent systemic antifungal azoles may increase risk of toxicity. - CYP3A4 inducers: strong inducers may reduce ketoconazole skin concentration (e.g., rifampicin creams).

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use may enhance skin irritation; monitor for worsening dermatitis. - Antihistamines: topical antihistamines may mask early signs of allergic reaction. - Hair dyes or cosmetics: may interfere with drug absorption; advise patient to avoid on treated area.